NCT06051149

Brief Summary

The approach toward FBSS involves conservative management that consists of physical therapy and medication which aims to optimize gait and posture and can improve muscle strength and physical function

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

October 3, 2023

Status Verified

September 1, 2023

Enrollment Period

1.9 years

First QC Date

September 17, 2023

Last Update Submit

September 30, 2023

Conditions

Keywords

caudal adhesiolysiscatheter type

Outcome Measures

Primary Outcomes (1)

  • pain score

    -difference in numeric rating scale at 6 months after intervention, minmal value 0 and maximum value 100 which is worst(more pain intensity)

    6 months after intervention

Secondary Outcomes (1)

  • functional outcome

    6 months after intervention

Study Arms (3)

Epidural Catheter

ACTIVE COMPARATOR

procedure Will be performed under sterile precautions utilizing fluoroscopy, RK needle.patient will be placed prone with a pillow under the abdomen.The sacral area draped from the top of the iliac crest to the bottom of the buttocks.The sacral Corns and the sacral hiatus will be palpated,is in the gluteal fold opposite the affected side will be infiltrated with lidocaine16gauge RK needle will be passed through the described entry point advanced to a point below the S3foramen to prevent S3nerve root damage.Placement will be confirmed by lateral and anteroposterior fluoroscopic views and after aspiration is negative for blood and CSF10mL of iohexol will be injected under fluoroscopy.Once the needle placement is confirmed to be in the epidural space, a lumbar epidurogram will be carried out utilizing approximately2to5 mL of contrast. then the bevel of the needle should face the ventrolateral aspect of the caudal canal.

Procedure: caudal adhesolysis using RACZ CatheterProcedure: caudal adhesiolysis using NAVI Catheter

RACZ Catheter

ACTIVE COMPARATOR

same as procedure described above but using RACZ Catheter set

Procedure: caudal adhesolysis using RACZ Catheter

NAVI catheter

ACTIVE COMPARATOR

same as procedure described above but using NAVI Catheter set

Procedure: caudal adhesiolysis using NAVI Catheter

Interventions

caudal adhesolysis for patients with failed back surgery syndrome using RACZ Catheter under fluroscopy

Epidural CatheterRACZ Catheter

caudal adhesolysis for patients with failed back surgery syndrome using NAVI Catheter under fluroscopy

Epidural CatheterNAVI catheter

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • previous back surgery of at least 6 months duration.
  • age ≥ 18.
  • failure of conventional pharmacological management.

You may not qualify if:

  • cauda equina syndrome.
  • pregnant or lactating women.
  • anti-coagulant therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Failed Back Surgery Syndrome

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsBack PainPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Will be performed in a sterile operating room under appropriate sterile precautions with help of assistant nurse who will open catheter set before principal investigator enter the operating room and the patient will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: double-blinded, prospective study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal Investigator

Study Record Dates

First Submitted

September 17, 2023

First Posted

September 22, 2023

Study Start

January 1, 2024

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

October 3, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share